ReviewClinical and translational radiation oncology2027
Dose-related cardiac side effects and its impact on survival following thoracic radiotherapy: A scoping review.
Review in Clinical and translational radiation oncology, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation dose to the heart is associated with various cardiac side effects. However, the specific cardiac and pulmonary structures that contribute to these toxicities remain incompletely understood. Moreover, although multiple factors contribute to reduced survival after radiotherapy, the role of radiation-induced cardiac toxicity remains underrecognized. This scoping review aimed to evaluate the associations between radiation dose to specific cardiac and pulmonary structures, cardiac side effects, and survival. A total of 137 clinical studies were analysed in accordance with the PRISMA guidelines. Associations between radiation dose and cardiac side effects were identified not only for the whole heart but also for specific cardiac substructures, including myocardial segments, coronary arteries, and the pericardium. Notably, radiation dose to the lungs was also associated with decline in cardiac function, suggesting that minimizing cardiac toxicity may require consideration of both local cardiac irradiation and non-local irradiation of adjacent organs, particularly the lungs. Direct evidence linking cardiac side effects to survival was limited. Nevertheless, the observed associations between higher radiation doses, increased cardiac toxicity, and poorer survival suggest a potential relationship that warrants further investigation. These findings support the hypothesis that reducing specific cardiac side effects may benefit from targeted sparing of the relevant cardiac and pulmonary substructures. While many radiation-related cardiac side effects are now recognized, further research is needed to identify and characterize previously unrecognized manifestations and to clarify their contribution to long-term survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.